Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide for Incomplete Microscopic Colitis
NCT02142634Phase 3Completed
- Sponsor
- Dr. Falk Pharma GmbH
- Start
- May 2014
- Primary completion
- Feb 2020
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of budesonide in microscopic colitis (MC), sponsored by Dr. Falk Pharma GmbH. Started May 2014; status: completed.
02
Drugs
budesonide
03
Conditions
microscopic colitis (MC)
Beyond the preview
Go deeper on NCT02142634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02142634.